A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Fredrikson S, McLeod E, Henry N, Pitcher A, Lowin J, Cuche M, Fajutrao L, Perard R, Bates D, Chan A